Specifically, elevated EMILIN-1 expression at the tumor margins correlated with enhanced cytotoxic T-cell recruitment, attenuation of TGF-β-mediated immunosuppression and improved patient prognosis [54]. The gene discussed is TGFB1; the disease is neoplasm.